The estimated Net Worth of Floyd E Bloom is at least $8.39 Milión dollars as of 16 July 2018. Dr Bloom owns over 20,000 units of Alkermes plc stock worth over $3,398,914 and over the last 13 years he sold ALKS stock worth over $4,990,678.
Dr has made over 17 trades of the Alkermes plc stock since 2011, according to the Form 4 filled with the SEC. Most recently he sold 20,000 units of ALKS stock worth $879,000 on 16 July 2018.
The largest trade he's ever made was selling 30,094 units of Alkermes plc stock on 31 January 2013 worth over $697,278. On average, Dr trades about 10,003 units every 85 days since 2011. As of 16 July 2018 he still owns at least 127,923 units of Alkermes plc stock.
You can see the complete history of Dr Bloom stock trades at the bottom of the page.
Dr. Floyd E. Bloom is the Founder at Alkermes plc.
Dr Bloom is 83, he's been the Founder of Alkermes plc since . There are 1 older and 21 younger executives at Alkermes plc. The oldest executive at Alkermes plc is Dr. Floyd E. Bloom M.D., 84, who is the Founder.
Floyd's mailing address filed with the SEC is Connaught House, Burlington Rd, Dublin 4, Ireland.
Over the last 13 years, insiders at Alkermes plc have traded over $407,046,771 worth of Alkermes plc stock and bought 86,119 units worth $2,034,840 . The most active insiders traders include Corp Plc Elan Science Three..., Richard F Pops a James M Frates. On average, Alkermes plc executives and independent directors trade stock every 5 days with the average trade being worth of $1,083,232. The most recent stock trade was executed by David Joseph Gaffin on 3 August 2024, trading 2,014 units of ALKS stock currently worth $53,512.
alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (cns) diseases. the company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. headquartered in dublin, ireland, alkermes plc has an r&d center in waltham, massachusetts; a research and manufacturing facility in athlone, ireland; and a manufacturing facility in wilmington, ohio. for more information, please visit alkermes’ website at www.alkermes.com.
Alkermes plc executives and other stock owners filed with the SEC include: